Virongy Biosciences Inc.
Manassas, VA
- UEI
- XGY3Q7EZ9JA7
- CAGE
- 99T06
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 11225 Assett Loop #111, Manassas, VA 20109, USA
- Website
- virongy.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $11,691 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cell lines vector production services | National Institute of Allergy and Infectious Diseases (NIH) | $11,691 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| PA22-176, sbir, phase i, development of a sars-COV-2 emerging variant infectivity and immune evasion panel to… | Office of Financial Resources (CDC) | $546,362 |
SBA capabilities narrative
Virongy Biosciences Inc. is a biotechnology company dedicated to advancing viral vector technologies, diagnostic tools, and the discovery of antivirals and antibodies for viral pathogens critical to public health and biodefense. Our patented platforms, including Alpha-pseudoviruses, advanced AAV encapsulation, and Infectin technologies, enable rapid quantification of antivirals and neutralizing antibodies, as well as enhanced gene therapy delivery. Committed to continuous innovation and backed by decades of virology expertise, we empower clients to accelerate discoveries and address emerging viral threats.
Quick answers
Is Virongy Biosciences Inc. registered in SAM.gov?
Yes. Virongy Biosciences Inc.'s SAM.gov registration is active through June 10, 2027.
How much has Virongy Biosciences Inc. received in federal contracts?
Federal contracts obligated $11,691 to Virongy Biosciences Inc. in fiscal years 2023 through 2027.
What is Virongy Biosciences Inc.'s most recent federal award?
Virongy Biosciences Inc.'s most recent federal grant award is PA22-176, sbir, phase i, development of a sars-COV-2 emerging variant infectivity and immune evasion panel to… (R43IP001230), from Office of Financial Resources (CDC), on September 30, 2023.
On GovTribe
See Virongy Biosciences Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors